Shukra Pharmaceuticals secures Pan-India distribution rights from Wockhardt
Shukra Pharmaceuticals Limited has been granted non-exclusive rights by Wockhardt Limited for distributing products across all ESIC/ESIS and Defence hospitals in India. The agreement, valid till March 2026, includes advanced antibiotics EMROK® and MIQNAF®.